Nanomedicine in treatment of breast cancer–A challenge to conventional therapy
M Afzal, KS Alharbi, NK Alruwaili, FA Al-Abassi… - Seminars in cancer …, 2021 - Elsevier
Amongst the various types of cancer, breast cancer is a highly heterogeneous disease and
known as the leading cause of death among women globally. The extensive interdisciplinary …
known as the leading cause of death among women globally. The extensive interdisciplinary …
Recent advances of dendrimers as multifunctional nano-carriers to combat breast cancer
Breast Cancer (BC) is a highly heterogeneous malignant carcinoma that is the most
frequently occurring cancer in women. The major types of BC are luminal A, basal-like …
frequently occurring cancer in women. The major types of BC are luminal A, basal-like …
Injectable nano drug delivery systems for the treatment of breast cancer
U Kafle, S Agrawal, AK Dash - Pharmaceutics, 2022 - mdpi.com
Breast cancer is the most diagnosed type of cancer, with 2.26 million cases and 685,000
deaths recorded in 2020. If left untreated, this deadly disease can metastasize to distant …
deaths recorded in 2020. If left untreated, this deadly disease can metastasize to distant …
A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy
Breast cancer being one of the most frequent cancers in women accounts for almost a
quarter of all cancer cases. Early and late-stage breast cancer outcomes have improved …
quarter of all cancer cases. Early and late-stage breast cancer outcomes have improved …
Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer
W Zeng, Y Luo, D Gan, Y Zhang, H Deng… - … in Bioengineering and …, 2023 - frontiersin.org
Triple positive breast cancer (TPBC) is one of the most aggressive breast cancer. Due to the
unique cell phenotype, aggressiveness, metastatic potential and lack of receptors or targets …
unique cell phenotype, aggressiveness, metastatic potential and lack of receptors or targets …
siRNA therapeutics: insights, challenges, remedies and future prospects
Introduction Among conventional and novel therapeutic approaches, the siRNA strategy
stands out for treating disease by silencing the gene responsible for the corresponding …
stands out for treating disease by silencing the gene responsible for the corresponding …
Recent advancements in the design of nanodelivery systems of siRNA for cancer therapy
RNA interference (RNAi) has increased the possibility of restoring RNA drug targets for
cancer treatment. Small interfering RNA (siRNA) is a promising therapeutic RNAi tool that …
cancer treatment. Small interfering RNA (siRNA) is a promising therapeutic RNAi tool that …
Recent advances in targeted nanocarriers for the management of Triple negative breast Cancer
Triple-negative breast cancer (TNBC) is a life-threatening form of breast cancer which has
been found to account for 15% of all the subtypes of breast cancer. Currently available …
been found to account for 15% of all the subtypes of breast cancer. Currently available …
Recent advances in multifunctional dendrimer-based nanoprobes for breast cancer theranostics
Breast cancer (BC) undoubtedly is one of the most common type of cancers amongst
women, which causes about 5 million deaths annually. The treatments and diagnostic …
women, which causes about 5 million deaths annually. The treatments and diagnostic …
[HTML][HTML] Lipid-coated ruthenium dendrimer conjugated with doxorubicin in anti-cancer drug delivery: Introducing protocols
S Michlewska, Z Garaiova, V Šubjakova… - Colloids and Surfaces B …, 2023 - Elsevier
One of the major limitations for the treatment of many diseases is an inability of drugs to
cross the cell membrane barrier. Different kinds of carriers are being investigated to improve …
cross the cell membrane barrier. Different kinds of carriers are being investigated to improve …